Healthcare Companies in Denmark

Cryos International is a leading international sperm and egg bank, headquartered in Denmark, dedicated to helping individuals and families worldwide realize their dream of parenthood.

For over 30 years, Cryos has been at the forefront of donor gamete provision, offering a vast selection of ethically sourced and rigorously screened sperm and egg donors representing diverse ethnicities and phenotypes. We connect patients with a world-leading selection of donors, ensuring access to high-quality frozen donor sperm and donor egg embryos for fertility treatments both domestically and internationally.

Cryos International operates with a commitment to quality, compliance, and patient safety, holding certifications including ISO 9001:2015 and adhering to stringent regulations across multiple countries. Our experienced team provides personalized guidance and support throughout the entire process, from donor selection to treatment coordination. We are the world’s largest sperm and egg bank, distributing to over 100 countries and empowering countless families to build their futures.

Liva Healthcare is Europe’s leading provider of scalable digital health coaching. Through an app Liva is providing personal human coaching programmes to help people manage obesity, pre-diabetes, type 2 diabetes and cardiovascular diseases. Liva is headquartered in Copenhagen with offices in London and Berlin, and the company's multi-award winning platform is now operational in nine countries across Europe and the South-Pacific. The company was founded in 2015 by the founders behind Europe’s leading independent health information portal, NetDoctor.com, Rune Bech and Carl Brandt, together with Kristoffer From. In 2017, Liva was selected by NHS England among 84 providers as a digital provider to their world-leading National Diabetes Prevention Programme (NDPP). Among Liva’s other major clients are insurance giants like AXA and Bupa, and pharmaceutical companies like Amgen and Novo Nordisk, and public and private healthcare providers across Europe. Through Liva’s app, users have access to a real human health coach, designing a personalised lifestyle change programme for them based on their individual needs. After a live video kick-off the participant then receives continuous professional guidance, support, motivation, and empathy via Liva's app. The goal is to help them prevent, manage or reverse chronic conditions through a new sustainable healthy lifestyle and behaviour changes. Participants can track their progress real-time via the app and engage with a support group of peers to keep them motivated. In several studies, Liva has been proven to drive substantial clinical outcomes, also in socio-economic backgrounds normally hard to reach. Liva is funded by VerlInvest, MIG, Digital Health Ventures, Santo Venture Capital, and Maj Invest. For more information visit livahealthcare.com

The health coaching revolution starts here Lenus partners with the world’s best health & fitness coaches to power their growth. We support the new generation in taking their coaching business to the next level. People who want to change the world. People who have the power to move not only bodies, but minds too. We empower coaches to be bold and boundless. And get limitless growth at their fingertips. Fusing together our innovative tech, strategic expertise & human connection, we’re fully equipped to handle the business of coaching, so that coaches can focus on delivering real value to their clients. We’re accelerating the holistic health revolution.

OpenTeleHealth is a medical certified cloud based platform for measuring health data at home, using and App and a wide range of medical devices. Doctors can view multiple patients’ data on a secure web portal. The platform is simple and scalable, and covers all chronic diseases, at a low price affordable even at a large scale. OpenTeleHealth uses a unique clinical workflow which gathers patient context, and not just measured health vitals. Visit www.opentelehealth.com for more information, or contact Henrik Ibsen, CEO on tel: +45 3070 1155

Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen.

At Dawn Health, we are human-centric digital health pioneers, with an industry leading product development platform. We build beautiful, bespoke & life-changing digital health products to improve the lives of patients around the world living with chronic diseases, specializing in the development of software as medical device (SaMD) and digital therapeutics (DTx). We Code to Save Lives and we work tirelessly everyday to achieve this vision, building digital health products driven by human insights and empathetic design. With a process that, from start to finish, is located in-house and driven by our expert teams, there are no outsourced resources. We build strong partnerships with the industry leaders through our approach and by ongoing collaboration throughout the entire product process, we deliver world class digital health products built at exceptional speed on our cutting edge Dawn Platform. Founded in Denmark in 2016, our international workforce lives by Danish values of exceptional design, globally leading innovative products and a workplace culture that supports employees in their professional and private lives. Our HQ is in Copenhagen and we operate on a global scale to deliver digital health solutions to those that need them.

AFYX Therapeutics is a private biopharmaceutical company focused on innovative approaches to treat mucosal diseases. The Company has developed the Rivelin patch, a breakthrough therapy for the treatment of mucosal diseases. Rivelin is designed to deliver a pharmaceutical drug uni-directionally to a mucosal surface using an occlusive, bio-adhesive and bio-degradable patch, with a long adhesion time and a high flexibility, conforming to the mucosal surface. AFYX's lead Rivelin patch product candidate seeks to treat the auto-immune, inflammatory disease oral lichen planus (OLP) through direct delivery of the drug clobetasol propionate. OLP may appear as lesions in the mouth that may cause burning, pain and other discomfort. OLP is considered an autoimmune disorder and requires regular monitoring given patients have increased risk of developing mouth cancer in the affected areas. No U.S. Food and Drug Administration (FDA) approved treatment exists, with today’s off-label treatment ranging from topical corticosteroids to laser ablation. It is estimated that OLP affects 1% to 2% of the population. Following successful results from a Phase 1b clinical study of the non-drug-loaded Rivelin patch in patients with OLP, AFYX has begun a Phase 2b clinical study of the clobetasol-loaded Rivelin patch in the United States and various countries in Europe. Shareholders include Sofinnova Ventures, Lundbeckfonden Emerge, Novo Seeds and Welfare Tech Invest.

Goodiebox is an online cosmetic company that provides cosmetics and beauty products.

NØIE is set out to help people. Our mission is to improve the quality of life for each individual with skin issues. We do so with a unique feedback-driven data model that is able to match individuals with a personalised and scientifically-backed solution customised on their skin’s needs.